Skip to main content
Clinical Trials/TCTR20150724002
TCTR20150724002
Not yet recruiting
Phase 1

The pilot study of plasma metabolite profile after administration of Ayurved Siriraj Herbal Recipe Ha-Rak (AVS022) in relation to platelet aggregation in individual healthy volunteer.

Mahidol University0 sites5 target enrollmentJuly 24, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
feverplatelet aggregation
Sponsor
Mahidol University
Enrollment
5
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 24, 2015
End Date
August 31, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18\-45 years
  • 2\. Body Mass Index (BMI) in the range of 18\-24 kg/m2
  • 3\. determined healthy by physical examination, assessment of drug abuse, medical history, and vital signs
  • 4\. Have normal or acceptable results for Complete Blood Count (CBC), Blood Urea Nitrogen (BUN), Serum Creatinine (Cr), Aspartate Amino Transminase (AST), Alanine Amino Transminase (ALT), Fasting Blood Sugar (FBS), Cholesterol, High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL) and Triglyceride
  • 5\. Be willing to participate and signed the informed consent form

Exclusion Criteria

  • 1\.Has history usage of other drugs, especially which can effect platelet aggregation e.g. aspirin, clopidogrel, ticlopidine
  • 2\.Has history of allergic reactions or allergy to drug especially paracetamol or NSAIDs
  • 3\.Has history of allergy reaction or allergy to AVS022 or one of its herbal components include Capparis micracantha , Clerodendrum indicum , Ficus racemosa , Harrisonia perforata., and Tiliacora triandra
  • 4\.Is regularly caffeine consumption (more than 1 time/week) and will consume it during the study period
  • 5\.Is regularly alcohol consumption (more than 1 time/week) or drug addict
  • 6\.Is a smoker or non smoker less than 14 days before enrollment
  • 7\.Is using supplements or vitamins within 14 days before enrollment and will use any of these during the study period
  • 8\.Is participation in other clinical studies within last 30 days
  • 9\.Is a pregnant woman or woman in breast feeding period or have positive pregnancy test
  • 10\.Has blood donation within last 90 days

Outcomes

Primary Outcomes

Not specified

Similar Trials